Agenda Topics- Cancer Personalised Medicine
- Companion Diagnostics
- Emerging Classes of Biomarkers for MDx
- Emerging technologies in MDx
- MDx for Infectious Diseases
- Next-Generation Sequencing: Its Impact on MDx
- Oncology Biomarkers
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyHolger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH Vladimir Tolstikov, Core Director, UC Davis Genome Center Elena Schwartz, CSO, Ariadne Diagnostics LLC Jake Strzelecki, Director, Business Development, Biodesix Robert Yamamoto, Founder, Zova Systems Leanna Levine, Founder & CEO, ALine, Inc. Enal Razvi, Managing Director, Select Biosciences Inc Steve Blair, Professor, University of Utah Nicole Pamme, Professor in Analytical Chemistry, Stockholm University Jan Weile, Project Leader, Institute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre Mao Mao, Research Fellow, Pfizer Global Research and Development Natasha Paul, Senior Scientific Investigator, TriLink BioTechnologies
|